Audio

Neelanjan Mukherjee discusses how RNA decay is essential for regulating a blood pressure-controlling hormone.

Erdem Gültekin Tamgüney discusses the future of neurodegeneration research and his work exploring the link between stroke and Parkinson’s disease.

Andrew Pelling shares how pursuing knowledge for its own sake breaks down interdisciplinary barriers and lays the foundation for ground-breaking research.

Karen Miga discusses how she and collaborators sequenced the missing parts of the human genome almost two decades after the first Human Genome Project published its results.

Welcome to Innovating Clinical Trials, a special edition podcast series produced by The Scientist’s Creative Services Team.

Aimée Parker shares how her childlike curiosity and collaborative spirit motivate her scientific pursuits.

Alysson Muotri shares how tapping into his inner creative spark fuels his pursuit of science.

Heather Kittredge and Sarah Evans discuss the environmental conditions that facilitate natural transformation in bacteria’s native habitat.  

Beate Peter shares how her “scientific bilingualism” is the driving force behind her philosophy of science.

Anthony Richardson discusses what makes Staph especially dangerous for people with diabetes.

Welcome to The Generative Biology Revolution, a special edition podcast series produced by The Scientist’s Creative Services Team.

Patrick Wilson discusses the challenges in designing universal vaccines and his work developing one for influenza.

Maya Kaelberer discusses her research investigating how sensory cells in the gut guide feeding behavior.

Don Ingber discusses how organ-on-a-chip technology helps identify, study, and combat viral variants that could cause the next pandemic.

John Glass describes why researchers constructed a synthetic unicellular organism and how it unravels the secrets of evolution.

Evangelos Kiskinis describes how the patient-derived iPSCs model of epilepsy help predict drug resistance.

Melissa Vos discusses how lipids’ good intentions become harmful in Parkinson’s Disease.

The adaptive and innate immune responses collaborate to attack T-cell resistant cancer cells.

Julian Ma discusses past, present, and future uses of plant biotechnology for disease treatments.